Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05248256 · ClinicalTrials.gov registry record · NA
Vertebral Marrow Attention Trial (VMAT)
A NA study, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT05248256 is a NA study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 12 participants.
The verdict
NCT05248256, a NA study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to see whether designing radiation to spare the vertebral bone marrow can limit the rates of lymphopenia during standard of care chemoradiation therapy and in the time to count recovery in the ensuing weeks. Secondary endpoints will examine whether this leads to improved disease control whether this is predictive of improved clinical outcomes such as rates of local recurrence (LR), metastasis free survival (MFS), overall survival (OS), and progression free survival (PFS) which will be followed prospectively up to 5 years.
Interventions
- OTHER Evidence-based radiation dose limitation to the vertebral bone marrow
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-09-29 |
| Est. Completion | 2024-09-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05248256
The ClinicalTrials.gov registry entry for NCT05248256 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Evidence-based radiation dose limitation to the vertebral bone marrow is the first listed.
NCT05248256 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05248256 about?
NCT05248256 is a clinical study titled "Vertebral Marrow Attention Trial (VMAT)". The purpose of this study is to see whether designing radiation to spare the vertebral bone marrow can limit the rates of lymphopenia during standard of care chemoradiation therapy and in the time to count recovery in the ensuing weeks. Secondary endpoints will examine whether this leads to improved...
What is the current status of trial NCT05248256?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2022-09-29. Estimated completion is 2024-09-18.
What interventions are being tested in trial NCT05248256?
The interventions under investigation include: Evidence-based radiation dose limitation to the vertebral bone marrow (OTHER).
Who is sponsoring clinical trial NCT05248256?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.